{
    "root": "cd328de3-26bc-43fe-8014-6fa3cee7f413",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Pregabalin"
    },
    "value": "20250515",
    "ingredients": [
        {
            "name": "PREGABALIN",
            "code": "55JG375S6M"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        }
    ],
    "indications": "pregabalin capsules indicated : management neuropathic pain associated diabetic peripheral neuropathy management postherpetic neuralgia adjunctive therapy treatment partial-onset seizures patients 1 month age older management fibromyalgia management neuropathic pain associated spinal cord injury",
    "contraindications": "adult , begin dosing 150 mg/day . partial-onset seizure dosing pediatric patients 1 month age older , refer section 2.4 . ( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) dosing recommendations : indication dosing regimen maximum dose dpn pain ( 2.2 ) 3 divided doses per day 300 mg/day within 1 week . phn ( 2.3 ) 2 3 divided doses per day 300 mg/day within 1 week . maximum dose 600 mg/day . adjunctive therapy partial-onset seizures pediatric adult patients weighing 30 kg ( 2.4 ) 2 3 divided doses per day maximum dose 600 mg/day . adjunctive therapy partial-onset seizures pediatric patients weighing less 30 kg ( 2.4 ) 1 month less 4 years : 3 divided doses per day 4 years older : 2 3 divided doses per day 14 mg/kg/day . fibromyalgia ( 2.5 ) 2 divided doses per day 300 mg/day within 1 week . maximum dose 450 mg/day . neuropathic pain associated spinal cord injury ( 2.6 ) 2 divided doses per day 300 mg/day within 1 week . maximum dose 600 mg/day . dose adjusted adult patients reduced renal function . ( 2.7 )",
    "warningsAndPrecautions": "pregabalin capsules 25 mg white cap/white body , size ‘ 5 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 10 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-758-90bottles 500 capsules ndc 65862-758-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-758-78 pregabalin capsules 50 mg white cap/white body , size ‘ 4 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 11 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-759-90bottles 100 capsules ndc 65862-759-01bottles 500 capsules ndc 65862-759-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-759-78 pregabalin capsules 75 mg orange cap/white body , size ‘ 4 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 12 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-760-90bottles 100 capsules ndc 65862-760-01bottles 500 capsules ndc 65862-760-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-760-78 pregabalin capsules 100 mg orange cap/orange body , size ‘ 3 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 13 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-761-90bottles 100 capsules ndc 65862-761-01bottles 500 capsules ndc 65862-761-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-761-78 pregabalin capsules 150 mg white cap/white body , size ‘ 2 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 14 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-762-90bottles 100 capsules ndc 65862-762-01bottles 500 capsules ndc 65862-762-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-762-78 pregabalin capsules 200 mg light orange cap/light orange body , size ‘ 1 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 15 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-763-90bottles 500 capsules ndc 65862-763-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-763-78 pregabalin capsules 225 mg light orange cap/white body , size ‘ 1 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 16 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-764-90bottles 500 capsules ndc 65862-764-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-764-78 pregabalin capsules 300 mg orange cap/white body , size ‘ 0 ’ hard gelatin capsule shells , imprinted “ z ” cap “ 17 ” body black ink , contain white off-white granular powder . bottles 90 capsules ndc 65862-765-90bottles 500 capsules ndc 65862-765-05cartons 100 ( 10 x 10 ) unit-dose capsules ndc 65862-765-78 storage handling store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "pregabalin capsules contraindicated patients known hypersensitivity pregabalin components . angioedema hypersensitivity occurred patients receiving pregabalin therapy [ ( 5.2 ) ] .",
    "indications_original": "Pregabalin capsules are indicated for:\n                  \n                  \n                     Management of neuropathic pain associated with diabetic peripheral neuropathy\n                     Management of postherpetic neuralgia\n                     Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older\n                     Management of fibromyalgia\n                     Management of neuropathic pain associated with spinal cord injury",
    "contraindications_original": "For adult indications, begin dosing at 150 mg/day. For partial-onset seizure dosing in pediatric patients 1 month of age and older, refer to section 2.4. ( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN Pain ( 2.2 ) 3 divided doses per day 300 mg/day within 1 week. PHN ( 2.3 ) 2 or 3 divided doses per day 300 mg/day within 1 week. Maximum dose of 600 mg/day. Adjunctive Therapy for Partial-Onset Seizures in Pediatric and Adult Patients Weighing 30 kg or More ( 2.4 ) 2 or 3 divided doses per day Maximum dose of 600 mg/day. Adjunctive Therapy for Partial-Onset Seizures in Pediatric Patients Weighing Less than 30 kg ( 2.4 ) 1 month to less than 4 years: 3 divided doses per day 4 years and older: 2 or 3 divided doses per day 14 mg/kg/day. Fibromyalgia ( 2.5 ) 2 divided doses per day 300 mg/day within 1 week. Maximum dose of 450 mg/day. Neuropathic Pain Associated with Spinal Cord Injury ( 2.6 ) 2 divided doses per day 300 mg/day within 1 week. Maximum dose of 600 mg/day. Dose should be adjusted in adult patients with reduced renal function. ( 2.7 )",
    "warningsAndPrecautions_original": "Pregabalin Capsules 25 mg are white cap/white body, size ‘5’ hard gelatin capsule shells, imprinted with “Z” on cap and “10” on body with black ink, and contain white to off-white granular powder.\n                  \n                  Bottles of 90 Capsules                                                                     NDC 65862-758-90Bottles of 500 Capsules                                                                   NDC 65862-758-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-758-78\n                  \n                  \n                     Pregabalin Capsules 50 mg are white cap/white body, size ‘4’ hard gelatin capsule shells, imprinted with “Z” on cap and “11” on body with black ink, and contain white to off-white granular powder.\n                      Bottles of 90 Capsules                                                                     NDC 65862-759-90Bottles of 100 Capsules                                                                   NDC 65862-759-01Bottles of 500 Capsules                                                                   NDC 65862-759-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-759-78\n                     \n                         Pregabalin Capsules 75 mg are orange cap/white body, size ‘4’ hard gelatin capsule shells, imprinted with “Z” on cap and “12” on body with black ink, and contain white to off-white granular powder.\n                      Bottles of 90 Capsules                                                                     NDC 65862-760-90Bottles of 100 Capsules                                                                   NDC 65862-760-01Bottles of 500 Capsules                                                                   NDC 65862-760-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-760-78\n                     \n                         Pregabalin Capsules 100 mg are orange cap/orange body, size ‘3’ hard gelatin capsule shells, imprinted with “Z” on cap and “13” on body with black ink, and contain white to off-white granular powder.\n                      Bottles of 90 Capsules                                                                     NDC 65862-761-90Bottles of 100 Capsules                                                                   NDC 65862-761-01Bottles of 500 Capsules                                                                   NDC 65862-761-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-761-78\n                     \n                         Pregabalin Capsules 150 mg are white cap/white body, size ‘2’ hard gelatin capsule shells, imprinted with “Z” on cap and “14” on body with black ink, and contain white to off-white granular powder.\n                      Bottles of 90 Capsules                                                                     NDC 65862-762-90Bottles of 100 Capsules                                                                   NDC 65862-762-01Bottles of 500 Capsules                                                                   NDC 65862-762-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-762-78\n                     \n                         Pregabalin Capsules 200 mg are light orange cap/light orange body, size ‘1’ hard gelatin capsule shells, imprinted with “Z” on cap and “15” on body with black ink, and  contain white to off-white granular powder.\n                      Bottles of 90 Capsules                                                                     NDC 65862-763-90Bottles of 500 Capsules                                                                   NDC 65862-763-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-763-78\n                     \n                         Pregabalin Capsules 225 mg are light orange cap/white body, size ‘1’ hard gelatin capsule shells, imprinted with “Z” on cap and “16” on body with black ink, and contain white to off-white granular powder.\n                      Bottles of 90 Capsules                                                                     NDC 65862-764-90Bottles of 500 Capsules                                                                   NDC 65862-764-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-764-78\n                     \n                         Pregabalin Capsules 300 mg are orange cap/white body, size ‘0’ hard gelatin capsule shells, imprinted with “Z” on cap and “17” on body with black ink, and contain white to off-white granular powder.\n                      Bottles of 90 Capsules                                                                     NDC 65862-765-90Bottles of 500 Capsules                                                                   NDC 65862-765-05Cartons of 100 (10 x 10) Unit-dose Capsules                                  NDC 65862-765-78\n                     \n                         Storage and Handling\n                  \n                  \n                  \n                     Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Pregabalin capsules are contraindicated in patients with known hypersensitivity to pregabalin or any of its components. Angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see Warnings and Precautions (5.2)]."
}